Stem Cell-Derived and Circulating Exosomal microRNAs as New Potential Tools for Diabetic Nephropathy Management

In recent years, a growing line of research has shown the participation of exosomal microRNAs in the pathophysiological processes of diabetic nephropathy (DN), which may provide effective therapeutic and biomarker tools for DN treatment.